SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 323 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $481,000 | -96.5% | 19,100 | -91.7% | 0.76% | -23.0% |
| Q2 2018 | $13,721,000 | +64.7% | 229,253 | +26.1% | 0.99% | +58.1% |
| Q1 2018 | $8,329,000 | -20.4% | 181,846 | -25.1% | 0.63% | -17.7% |
| Q2 2017 | $10,458,000 | -7.1% | 242,661 | -32.5% | 0.76% | -2.9% |
| Q1 2017 | $11,259,000 | +69.4% | 359,739 | +36.7% | 0.78% | +71.4% |
| Q4 2016 | $6,645,000 | +62.4% | 263,184 | +59.0% | 0.46% | +55.3% |
| Q3 2016 | $4,093,000 | -41.9% | 165,511 | -67.1% | 0.30% | -41.0% |
| Q3 2015 | $7,047,000 | -17.4% | 502,319 | 0.0% | 0.50% | -21.4% |
| Q2 2015 | $8,529,000 | – | 502,319 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |